Internal Medicine · Brooklyn, NY
NPI
1619989514
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
3632 Nostrand Ave Ste 3
Brooklyn, NY, 11229
Phone (718) 615-0162
Groups this clinician bills Medicare through
Medicare paid, 2024
$365K
5,862 services
Medicare patients, 2024
776
Average age 77
Drug cost, 2024
$9.4M
43,421 prescriptions
Company payments, 2025
$1,494
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Boris Khorets was code 99214 (office e&m - established), 1,836 times for 642 patients. In total Boris Khorets billed 5,862 services in 47 codes, and Medicare paid $365K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,836 | 642 | $105.62 | $194K |
| 99213 Office E&M - Established | Office | 1,284 | 484 | $73.85 | $95K |
| 36415 Venipuncture Blood Collection | Office | 1,144 | 596 | $8.61 | $9,852 |
| 93000 Electrocardiogram | Office | 417 | 324 | $11.33 | $4,725 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 188 | 188 | $147.61 | $28K |
| 81002 Clinical Chemistry | Office | 109 | 82 | $3.41 | $372 |
| 96372 Injection Administration | Office | 60 | 30 | $11.78 | $707 |
| 82962 Clinical Chemistry | Office | 59 | 41 | $3.21 | $189 |
| G0008 Administration of influenza virus vaccine | Office | 58 | 58 | $37.09 | $2,151 |
| 90662 Vaccine Product | Office | 53 | 53 | $81.82 | $4,336 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 47 | 21 | $0.88 | $41.47 |
| 99204 Office E&M - New | Office | 43 | 43 | $133.83 | $5,755 |
| 96360 Intravenous Infusion, Hydration | Office | 33 | 18 | $29.19 | $963 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 33 | 16 | $1.00 | $32.91 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 30 | 30 | $187.29 | $5,619 |
By year: 2022 $481K for 7,833 services; 2023 $455K for 6,826 services; 2024 $365K for 5,862 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,144 | 596 | $8.61 | $9,852 |
| 81002 Clinical Chemistry | 109 | 82 | $3.41 | $372 |
| 82962 Clinical Chemistry | 59 | 41 | $3.21 | $189 |
Medicare prescription drug claims, 2024
In 2024, the drug Boris Khorets prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,752 prescriptions and refills. In total Boris Khorets wrote 43,421 Medicare prescriptions that cost $9.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,752 | 2,952 | 330 | $14K |
| Metoprolol Succinate Generic | 1,548 | 2,506 | 275 | $12K |
| Amlodipine Besylate Generic | 1,222 | 1,983 | 229 | $2,831 |
| Diclofenac Sodium Generic | 1,187 | 1,224 | 174 | $689K |
| Atorvastatin Calcium Generic | 937 | 1,491 | 172 | $4,473 |
| Vascepa Icosapent Ethyl | 845 | 920 | 118 | $311K |
| Linzess Linaclotide | 758 | 814 | 117 | $416K |
| Eliquis Apixaban | 729 | 864 | 105 | $522K |
| Metformin Hcl Generic | 711 | 1,161 | 131 | $2,360 |
| Furosemide Generic | 697 | 855 | 117 | $1,142 |
| Creon Lipase/Protease/Amylase | 687 | 758 | 123 | $777K |
| Omeprazole Generic | 621 | 907 | 117 | $3,467 |
| Levothyroxine Sodium Generic | 617 | 938 | 101 | $4,460 |
| Metoprolol Tartrate Generic | 518 | 818 | 96 | $1,686 |
| Esomeprazole Magnesium Generic | 511 | 615 | 78 | $13K |
Brand drugs: 10,874 claims; generic drugs: 31,939 claims; opioid claims: 200.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Boris Khorets $1,494 ($1,494 in general payments such as food, travel and fees) from 12 companies. The largest payer was Aimmune Therapeutics, Inc. with $475.
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 17 | $475 |
| Abbvie Inc. ABBV | 17 | $411 |
| Novo Nordisk Inc NVO | 12 | $140 |
| GlaxoSmithKline, LLC. GSK | 3 | $92.02 |
| Amgen Inc. AMGN | 4 | $91.18 |
| Pfizer Inc. PFE | 3 | $66.24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63.28 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $51.12 |
| Astellas Pharma US Inc 4503.T | 1 | $32.11 |
| Lilly USA, LLC LLY | 1 | $26.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.